


The Fund aims to achieve capital growth and income from investment in a portfolio of funds managed by Threadneedle Investments.
| Name | % Net Assets |
|---|---|
| United Kingdom Gilt 4.5 07/03/2019 | 1.8% |
| BP PLC | 1.8% |
| Bundesrepublik Deutschland 3.5 04/07/2019 | 1.8% |
| GlaxoSmithKline PLC | 1.7% |
| United States Treasury Note/Bond 4.5 15/08/2039 | 1.5% |
| Bundesrepublik Deutschland 4.75 04/07/2040 | 1.4% |
| Vodafone Group PLC | 1.3% |
| Netherlands Government Bond 4 15/07/2019 | 1.3% |
| British American Tobacco PLC | 1.3% |
| AstraZeneca PLC | 1.2% |
| Key | % Net Assets |
|---|---|
| 1.8% | |
| 1.8% | |
| 1.8% | |
| 1.7% | |
| 92.9% |
| Date | 09-Apr-2021 |
|---|---|
| Bid | 185.80p |
| Offer | 185.80p |
| Currency | GBP |
| Change | 0.50p |
| % | 0.27% |
| YTD change | 185.80p |
| YTD % | n/a |
| Fund Inception | 26/08/1997 |
|---|---|
| Fund Manager | Sarah Arkle / Alex Lyle |
| TER | 1.21 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £500000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.08 |
You are here: research